Glembatumumab vedotin
Glembatumumab vedotin (CDX-011) is an antibody-drug conjugate with potent anticancer effects, utilized in the study of triple negative breast cancer (TNBC) .
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
Approximatel 149.16 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Microtubule Associated | Antibody-Drug Conjugates (ADCs)
CAS Number
1182215-65-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
